Focus on lung cancer

Same author

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Cancer research·2025

Same author

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis.

International journal of molecular sciences·2023

Same author

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.

Nature cancer·2022

Same author

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

Journal of the National Cancer Institute·2021

Same author

SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other Cancers.

IEEE life sciences letters·2021

Same author

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.

Communications biology·2021

Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026

Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026

Same journal

Intratumoral B cells under stress.

Cancer cell·2026

Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026

Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026

Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026

Related Experiment Videos

Focus on lung cancer

Related Concept Videos

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis.

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other Cancers.

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Intratumoral B cells under stress.

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

OpenIO: An open framework for AI-native immunotherapy.

Related Experiment Videos

Focus on lung cancer

Related Concept Videos

Related Articles

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis.

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other Cancers.

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Intratumoral B cells under stress.

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

OpenIO: An open framework for AI-native immunotherapy.